Drug Patents owned by St Renatus

1. List of Kovanaze drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9308191 ST RENATUS Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration
Apr, 2030

(7 years from now)

US8580282 ST RENATUS Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration
Apr, 2030

(7 years from now)

Drugs and Companies using OXYMETAZOLINE HYDROCHLORIDE; TETRACAINE HYDROCHLORIDE ingredient

Market Authorisation Date: 29 June, 2016

Treatment: Method of anesthetizing at least a portion of the maxillary dental arch

Dosage: SPRAY, METERED;NASAL

More Information on Dosage

KOVANAZE family patents

10

United States

3

Japan

2

South Africa

2

Australia

2

Korea, Republic of

2

New Zealand

2

China

1

Brazil

1

Portugal

1

Denmark

1

Poland

EA

1

EA

1

Canada

1

Spain

1

Mexico

1

European Union

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in